Li Wei Jin - Net Worth and Insider Trading

Li Wei Jin Net Worth

The estimated net worth of Li Wei Jin is at least $20 Million dollars as of 2024-06-22. Li Wei Jin is the Director of Zhejiang Hisoar Pharmaceutical Co Ltd and owns about 3,687,500 shares of Zhejiang Hisoar Pharmaceutical Co Ltd (SZSE:002099) stock worth over $20 Million. Details can be seen in Li Wei Jin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Li Wei Jin has not made any transactions after 2015-05-13 and currently still holds the listed stock(s).

Transaction Summary of Li Wei Jin

To

Li Wei Jin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Li Wei Jin owns 1 companies in total, including Zhejiang Hisoar Pharmaceutical Co Ltd (SZSE:002099) .

Click here to see the complete history of Li Wei Jin’s form 4 insider trades.

Insider Ownership Summary of Li Wei Jin

Ticker Comapny Transaction Date Type of Owner
SZSE:002099 Zhejiang Hisoar Pharmaceutical Co Ltd 2015-05-13 Director

Li Wei Jin Latest Holdings Summary

Li Wei Jin currently owns a total of 1 stock. Li Wei Jin owns 3,687,500 shares of Zhejiang Hisoar Pharmaceutical Co Ltd (SZSE:002099) as of May 13, 2015, with a value of $20 Million.

Latest Holdings of Li Wei Jin

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SZSE:002099 Zhejiang Hisoar Pharmaceutical Co Ltd 2015-05-13 3,687,500 5.36 19,765,000

Holding Weightings of Li Wei Jin


Li Wei Jin Form 4 Trading Tracker

According to the SEC Form 4 filings, Li Wei Jin has made a total of 0 transactions in Zhejiang Hisoar Pharmaceutical Co Ltd (SZSE:002099) over the past 5 years. The most-recent trade in Zhejiang Hisoar Pharmaceutical Co Ltd is the sale of 500,000 shares on May 13, 2015, which brought Li Wei Jin around $10 Million.

Insider Trading History of Li Wei Jin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Li Wei Jin Trading Performance

GuruFocus tracks the stock performance after each of Li Wei Jin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Li Wei Jin is -12.01%. GuruFocus also compares Li Wei Jin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Li Wei Jin within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Li Wei Jin's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Li Wei Jin

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 5.37 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 3.54 LIMIT LIMIT LIMIT LIMIT LIMIT

Li Wei Jin Ownership Network

Ownership Network List of Li Wei Jin

No Data

Ownership Network Relation of Li Wei Jin

Insider Network Chart

Li Wei Jin Owned Company Details

What does Zhejiang Hisoar Pharmaceutical Co Ltd do?

Who are the key executives at Zhejiang Hisoar Pharmaceutical Co Ltd?

Li Wei Jin is the Director of Zhejiang Hisoar Pharmaceutical Co Ltd. Other key executives at Zhejiang Hisoar Pharmaceutical Co Ltd include Directors & executives Yang Si Wei , Executives Xu Guo Rui , and Secretary Dong Xu Hua Qing .

Zhejiang Hisoar Pharmaceutical Co Ltd (SZSE:002099) Insider Trades Summary

Over the past 18 months, Li Wei Jin made no insider transaction in Zhejiang Hisoar Pharmaceutical Co Ltd (SZSE:002099). Other recent insider transactions involving Zhejiang Hisoar Pharmaceutical Co Ltd (SZSE:002099) include a net purchase of 871,500 shares made by wang yang chao ,

In summary, during the past 3 months, insiders sold 0 shares of Zhejiang Hisoar Pharmaceutical Co Ltd (SZSE:002099) in total and bought 175,000 shares, with a net purchase of 175,000 shares. During the past 18 months, 0 shares of Zhejiang Hisoar Pharmaceutical Co Ltd (SZSE:002099) were sold and 871,500 shares were bought by its insiders, resulting in a net purchase of 871,500 shares.

Zhejiang Hisoar Pharmaceutical Co Ltd (SZSE:002099)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Zhejiang Hisoar Pharmaceutical Co Ltd Insider Transactions

No Available Data

Li Wei Jin Mailing Address

Above is the net worth, insider trading, and ownership report for Li Wei Jin. Currently GuruFocus does not have mailing address information for Li Wei Jin.

Discussions on Li Wei Jin

No discussions yet.